This work is licensed under a Creative Commons Attribution 4.0 International License.
Tritrp-hArg
General Information
DRACP ID DRACP00952
Peptide Name Tritrp-hArg
Sequence VXXFPWWWPFLXX
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin porcine cathelicidin peptide
Type Synthetic peptide
Classification
Active ACP
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| Jurkat | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | IC50=13.3 µM | MTT assay | 24h | 1 |
Hemolytic Activity RBC: IC50=41.3 µM
Normal (non-cancerous) Cytotoxicity PBMC: IC50=19.4 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X=hArg=homo-arginine
Chiral L
Physicochemical Information
Formula C72H76N12O6
Absent amino acids ACDEGHIKMNQRSTY
Common amino acids X
Mass 185968
Pl 6.11
Basic residues 0
Acidic residues 0
Hydrophobic residues 7
Net charge 0
Boman Index 2191
Hydrophobicity 59.23
Aliphatic Index 52.31
Half Life
/
Extinction Coefficient cystines 16500
Absorbance 280nm 1375
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32126228
Title Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin
Doi 10.1016/j.bbamem.2020.183228
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.